Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
Recruiting
N/A
Interventional Study
Radiation Exposure
Lung Embolism
Lung Cancer
Pneumonia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 100 (estimated)
- Sponsor
- University of Zurich · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* CT SCAN for pulmonary nodule detection/follow up
* CT SCAN for pneumonia detection/follow up
Exclusion Criteria:
* under 18
* BMI over 30
Contacts
No contact information available.